CompletedNot Applicable

Endometrial Dating by Ex-vivo Imaging of Endometrial Biopsies of In-vitro Fertilization Candidate Participants

Israel49 participantsStarted 2019-06-16

Plain-language summary

To evaluate the correlation between cycle day determination by clinical signs, study participant testimony, endometrium histopathology biopsy and ex-vivo imaging of the uterus endometrium.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Gender: Female
✓. Age: 18-40
✓. Belong to one of the three following groups:
✓. Women undergoing fertility treatment, and are regularly ovulating
✓. Women whose fertility status is unknown
✓. Women proved to be fertile (previous spontaneous successful pregnancy)

Exclusion criteria

✕. Women with known existing endometrial pathology
✕. Women with known history of infertility due to oligo-ovulation or anovulation.
✕. Women with medical history of malignant tumors in their reproductive system
✕. Women that are on any hormonal medications or treatments (excluding hormonal contraception in previous cycles)
✕. Women that are on hormonal contraception treatment in their current cycle
✕. Women with intrauterine device
✕. Women menstruating on the day of the biopsy collection

What they're measuring

Correlation between image-based endometrial dating and that of histology

Timeframe: 12 months

Trial details

NCT IDNCT04288843

SponsorFertigo Medical Ltd

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Endometrium trials